Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Active, not recruiting · NCT03197506 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, gliosarcoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-22 | NCT03197506 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Hospital in Arizona | Phoenix | United States | 120 |
| Mayo Clinic in Arizona | Scottsdale | United States | 191 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |